Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion type Assertion NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_head.
- NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion wasGeneratedBy ECO_0000203 NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_provenance.
- NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion wasDerivedFrom befree-20150227 NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_provenance.
- NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion SIO_000772 21220499 NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_provenance.
- NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion evidence source_evidence_literature NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_provenance.
- NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_assertion description "[Sorafenib, a VEGFR inhibitor with activity against RAF kinase, is active against hepatocellular carcinoma (HCC); however, the possible involvement of sorafenib in the EMT remains unclear.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP865373.RAbnF1aEriIt8oNQXLwRLDSc_7nSxFek_sKbJ3_Sa18fE130_provenance.